Satellos Historical Income Statement
| MSCL Stock | 0.70 0.01 1.45% |
Historical analysis of Satellos Bioscience income statement accounts such as Total Revenue of 0.0 can show how well Satellos Bioscience performed in making a profits. Evaluating Satellos Bioscience income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Satellos Bioscience's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Satellos Bioscience latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Satellos Bioscience is a good buy for the upcoming year.
Satellos |
About Satellos Income Statement Analysis
Satellos Bioscience Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Satellos Bioscience shareholders. The income statement also shows Satellos investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Satellos Bioscience Income Statement Chart
Add Fundamental
Cost Of Revenue
Cost of Revenue is found on Satellos Bioscience income statement and represents the costs associated with goods and services Satellos Bioscience provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Most accounts from Satellos Bioscience's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Satellos Bioscience current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Satellos Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. At this time, Satellos Bioscience's Selling General Administrative is very stable compared to the past year. As of the 25th of November 2025, Research Development is likely to grow to about 20.6 M, while Depreciation And Amortization is likely to drop about 19 K.
| 2022 | 2023 | 2024 | 2025 (projected) | Total Operating Expenses | 8.4M | 15.5M | 27.8M | 29.2M | Cost Of Revenue | 3.7M | 8.8M | 20K | 19K |
Satellos Bioscience income statement Correlations
Click cells to compare fundamentals
Satellos Bioscience Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Satellos Bioscience income statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Depreciation And Amortization | 422.0 | 165.7K | 337K | 7K | 20K | 19K | |
| Selling General Administrative | 182.4K | 1.4M | 4.0M | 6.1M | 8.2M | 8.6M | |
| Gross Profit | (48.2K) | (119.9K) | (3.7M) | (8.8M) | (20K) | (21K) | |
| Other Operating Expenses | 1.5M | 4.7M | 8.4M | 15.5M | (27.8M) | (26.4M) | |
| Operating Income | (1.5M) | (4.7M) | (8.4M) | (15.5M) | (27.8M) | (26.4M) | |
| Ebit | (1.6M) | (4.8M) | (8.4M) | (15.7M) | (28.1M) | (26.7M) | |
| Research Development | 892.8K | 2.0M | 3.7M | 8.8M | 19.6M | 20.6M | |
| Ebitda | (1.6M) | (4.6M) | (8.1M) | (15.7M) | (28.1M) | (26.7M) | |
| Cost Of Revenue | 48.2K | 119.9K | 3.7M | 8.8M | 20K | 19K | |
| Total Operating Expenses | 1.4M | 4.7M | 8.4M | 15.5M | 27.8M | 29.2M | |
| Income Before Tax | (1.6M) | (15.5M) | (11.3M) | (15.9M) | (28.1M) | (26.7M) | |
| Total Other Income Expense Net | 349.8K | (8.9M) | (2.9M) | (426K) | (291K) | (305.6K) | |
| Net Income | (1.6M) | (15.5M) | (11.3M) | (15.9M) | (28.1M) | (26.7M) |
Pair Trading with Satellos Bioscience
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Satellos Bioscience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Satellos Bioscience will appreciate offsetting losses from the drop in the long position's value.Moving together with Satellos Stock
The ability to find closely correlated positions to Satellos Bioscience could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Satellos Bioscience when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Satellos Bioscience - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Satellos Bioscience to buy it.
The correlation of Satellos Bioscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Satellos Bioscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Satellos Bioscience moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Satellos Bioscience can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Satellos Stock
Satellos Bioscience Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Satellos Bioscience shareholders. The income statement also shows Satellos investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).